Inventor · Sugar Land, TX, US

Timothy Heffernan

16Patents

6h-index

28Co-inventors

58Inventor score

Filing activity: Jul 2, 2015 → Sep 6, 2023

Most-cited inventions

Patent	Title	Area	Cited by	Status
US9809588B2	GLS1 inhibitors for treating disease	Chemistry; Metallurgy	15	Active
US10125128B2	GLS1 inhibitors for treating disease	Chemistry; Metallurgy	13	Active
US10344025B2	GLS1 inhibitors for treating disease	Chemistry; Metallurgy	12	Active
US10766892B2	GLS1 inhibitors for treating disease	Chemistry; Metallurgy	9	Active
US10722487B2	Glutaminase inhibitor therapy	Human Necessities	9	Active
US11045443B2	Glutaminase inhibitor therapy	Human Necessities	7	Active
US11370786B2	GLS1 inhibitors for treating disease	Chemistry; Metallurgy	6	Active
US10738043B2	GLS1 inhibitors for treating disease	Chemistry; Metallurgy	6	Active
US11713313B2	GLS1 inhibitors for treating disease	Chemistry; Metallurgy	3	Active
US11786500B2	Glutaminase inhibitor therapy	Human Necessities	2	Active
US11958849B2	GLS1 inhibitors for treating disease	Chemistry; Metallurgy	2	Active
US11311609B2	Regulating chimeric antigen receptors	Chemistry; Metallurgy	1	Active
US12336976B2	Glutaminase inhibitor therapy	Human Necessities	0	Active
US12023385B2	Tunable endogenous protein degradation with heterobifunctional compounds	Chemistry; Metallurgy	0	Active
US11293023B2	Tunable endogenous protein degradation	Chemistry; Metallurgy	0	Active
US11046954B2	Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.